🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rodrigo T. Cartaxo

University of Michigan

ORCID: 0009-0001-2011-5695

Also affiliated with Michigan Medicine, Cancer Research Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma”.

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

Neuro-Oncology(2022)10.1093/neuonc/noac030

N/A

3.4DataRank · unranked

122 citations

Kyle Wierzbicki, Rohinton S. Tarapore, Karthik Ravi, Chase Thomas, Rodrigo T. Cartaxo +27 more

A road map for the treatment of pediatric diffuse midline glioma

Cancer Cell(2023)10.1016/j.ccell.2023.11.002

N/A

0.653DataRank · unranked

24 citations

Wajd N. Al‐Holou, Marta M. Alonso, Jamie N. Anastas, Pratiti Bandopadhayay, Tara Barron +70 more

Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma

Journal of Clinical Investigation(2020)10.1172/jci133310

N/A

0.652DataRank · unranked

76 citations

Viveka Nand Yadav, Rodrigo T. Cartaxo, Ruby Siada, Chase Thomas, Jessica Cummings +28 more

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0131

N/A

0DataRank · unranked

154 citations

Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota +79 more

Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

Acta Neuropathologica(2023)10.1007/s00401-023-02640-7

N/A

0DataRank · unranked

35 citations

Sunjong Ji, Alberto Pïcca, Marc Sanson, Mekka Garcia, Matija Snuderl +25 more

H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.13.544658

N/A

0DataRank · unranked

7 citations

Santiago Haase, Kaushik Banerjee, Ziwen Zhu, Brandon L. McClellan, Anzar Mujeeb +39 more

Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma

medRxiv(2020)10.1101/2019.12.28.19015974

N/A

0DataRank · unranked

6 citations

Viveka Nand Yadav, Rodrigo T. Cartaxo, Ruby Siada, Chase Thomas, Jessica Cummings +28 more

Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine

Frontiers in Oncology(2022)10.3389/fonc.2022.922928

N/A

0DataRank · unranked

44 citations

Dana Messinger, Jessica Cummings, Joshua Bradin, Abed Rahman Kawakibi, Clarissa May Babila +8 more